









Markets
/
Stocks
/
nasdaq-cgem
/

Cullinan Therapeutics Inc

CGEM

6.340USD

+0.410+6.91%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

374.53MMarket Cap

LossP/E TTM



Cullinan Therapeutics Inc

6.340

+0.410+6.91%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Total revenue

----

--0.00

-100.00%0.00

--0.00

--18.94M

----

Revenue

----

--0.00

-100.00%0.00

--0.00

--18.94M

----

Operating expenses

51.51%75.80M

27.93%55.00M

21.02%55.05M

9.04%48.85M

33.03%50.03M

-31.50%42.99M

39.49%45.48M

50.52%44.80M

6.21%37.60M

92.17%62.76M

-5.06%32.61M

61.99%29.77M

113.24%35.41M

93.35%32.66M

17.74%34.35M

59.80%18.38M

--16.60M

--16.89M

485.92%29.17M

65.38%11.50M

--4.98M

--6.95M

R&D expenses

68.32%61.03M

35.28%41.46M

16.20%40.49M

4.98%35.51M

32.38%36.26M

-41.17%30.65M

63.44%34.85M

71.85%33.82M

3.71%27.39M

112.32%52.10M

2.12%21.32M

55.21%19.68M

124.24%26.41M

97.63%24.54M

25.55%20.88M

27.91%12.68M

--11.78M

--12.41M

337.38%16.63M

87.89%9.91M

--3.80M

--5.28M

Depreciation, depletion, and amortization

0.00%77.00K

0.00%76.00K

0.00%77.00K

-5.00%76.00K

-4.94%77.00K

5.56%76.00K

30.51%77.00K

788.89%80.00K

575.00%81.00K

453.85%72.00K

391.67%59.00K

-30.77%9.00K

-7.69%12.00K

-13.33%13.00K

-20.00%12.00K

-13.33%13.00K

--13.00K

--15.00K

-11.76%15.00K

-6.25%15.00K

--17.00K

--16.00K

Operating profit

-51.51%-75.80M

-27.93%-55.00M

-21.02%-55.05M

-9.04%-48.85M

-33.03%-50.03M

31.50%-42.99M

-39.49%-45.48M

-50.52%-44.80M

-6.21%-37.60M

-92.17%-62.76M

5.06%-32.61M

-61.99%-29.77M

-113.24%-35.41M

-1690.70%-32.66M

-17.74%-34.35M

-59.80%-18.38M

---16.60M

--2.05M

-485.92%-29.17M

-65.38%-11.50M

---4.98M

---6.95M

Net non-operating interest income (expenses)

Non-operating interest income

-26.60%5.92M

15.58%6.58M

26.96%7.51M

42.59%8.38M

51.65%8.07M

26.29%5.69M

75.89%5.92M

149.89%5.88M

663.56%5.32M

2188.32%4.51M

2355.47%3.36M

1894.07%2.35M

302.89%697.00K

302.04%197.00K

73.42%137.00K

-36.22%118.00K

--173.00K

--49.00K

-68.65%79.00K

83.17%185.00K

--252.00K

--101.00K

Special income (expenses)

----

--0.00

100.00%0.00

----

--0.00

---440.00K

-100.00%0.00

----

--0.00

--275.08M

----

---681.00K

----

Other non-operating income (expenses)

-151.39%-181.00K

-93.18%-85.00K

105.13%6.00K

-149.44%-89.00K

-204.35%-72.00K

-141.12%-44.00K

-139.26%-117.00K

--180.00K

128.63%69.00K

--107.00K

7350.00%298.00K

100.00%0.00

-2912.50%-241.00K

100.00%0.00

133.33%4.00K

---2.00K

---8.00K

---2.00K

-200.00%-12.00K

-100.00%0.00

---4.00K

--3.00K

Income before tax

-66.69%-70.06M

-29.89%-48.50M

-19.77%-47.53M

-3.51%-40.56M

-30.47%-42.03M

35.78%-37.34M

-37.10%-39.69M

-42.94%-39.18M

-113.41%-32.21M

-79.12%-58.14M

15.38%-28.95M

-50.13%-27.41M

1560.76%240.13M

-2387.53%-32.46M

-17.52%-34.21M

-61.38%-18.26M

---16.44M

--1.42M

-515.22%-29.11M

-65.19%-11.31M

---4.73M

---6.85M

Income tax

----

100.83%117.00K

----

-660.06%-14.12M

100.00%0.00

-100.00%0.00

100.00%0.00

---1.86M

---2.52M

--66.07M

---19.57M

----

Income after tax

-66.69%-70.06M

-29.89%-48.50M

-86.39%-47.65M

-3.51%-40.56M

-30.47%-42.03M

35.78%-37.34M

5.63%-25.56M

-57.42%-39.18M

-118.51%-32.21M

-350.99%-58.14M

20.81%-27.09M

-36.32%-24.89M

1158.85%174.06M

-1008.53%-12.89M

-17.52%-34.21M

-61.38%-18.26M

---16.44M

--1.42M

-515.22%-29.11M

-65.19%-11.31M

---4.73M

---6.85M

Net income from continuous operations

-66.69%-70.06M

-29.89%-48.50M

-86.39%-47.65M

-3.51%-40.56M

-30.47%-42.03M

35.78%-37.34M

5.63%-25.56M

-57.42%-39.18M

-118.51%-32.21M

-350.99%-58.14M

20.81%-27.09M

-36.32%-24.89M

1158.85%174.06M

-1008.53%-12.89M

-17.52%-34.21M

-61.38%-18.26M

---16.44M

--1.42M

-515.22%-29.11M

-65.19%-11.31M

---4.73M

---6.85M

Other net gains and losses

----

---117.00K

----

Net Income attributable to non-controlling interests

--0.00

100.00%0.00

--0.00

-7.26%-192.00K

-475.16%-1.76M

100.00%0.00

77.46%-179.00K

81.91%-306.00K

90.54%-86.00K

-3.74%-833.00K

-153.32%-794.00K

-122.63%-1.69M

37.57%-909.00K

---803.00K

--1.49M

-369.14%-760.00K

-447.37%-1.46M

---162.00K

---266.00K

Net income attributable to controlling interests

-66.69%-70.06M

-30.56%-48.50M

-100.17%-47.65M

-3.51%-40.56M

-30.47%-42.03M

35.91%-37.15M

11.12%-23.80M

-57.97%-39.18M

-118.42%-32.21M

-379.10%-57.96M

17.63%-26.78M

-42.96%-24.80M

1218.56%174.90M

-17182.86%-12.10M

-14.70%-32.51M

-76.00%-17.35M

---15.64M

---70.00K

-520.40%-28.35M

-49.75%-9.86M

---4.57M

---6.58M

Net income attributable to common shareholders

-66.69%-70.06M

-30.56%-48.50M

-100.17%-47.65M

-3.51%-40.56M

-30.47%-42.03M

35.91%-37.15M

11.12%-23.80M

-57.97%-39.18M

-118.42%-32.21M

-379.10%-57.96M

17.63%-26.78M

-42.96%-24.80M

1218.56%174.90M

-17182.86%-12.10M

-14.70%-32.51M

-76.00%-17.35M

---15.64M

---70.00K

-520.40%-28.35M

-49.75%-9.86M

---4.57M

---6.58M

Basic earnings per share

-55.49%-1.19

4.67%-0.82

-46.20%-0.81

24.17%-0.70

5.32%-0.76

39.38%-0.86

5.00%-0.56

-68.60%-0.92

-120.69%-0.81

-423.27%-1.42

23.41%-0.59

-36.16%-0.54

1179.22%3.90

-16204.19%-0.27

-11.61%-0.76

-67.73%-0.40

---0.36

--0.00

-520.39%-0.68

-49.75%-0.24

---0.11

---0.16

Diluted earnings per share

-55.49%-1.19

4.67%-0.82

-46.20%-0.81

24.17%-0.70

5.32%-0.76

39.38%-0.86

5.00%-0.56

-68.60%-0.92

-121.38%-0.81

-423.27%-1.42

23.41%-0.59

-36.16%-0.54

1144.14%3.77

-16204.19%-0.27

-11.61%-0.76

-67.73%-0.40

---0.36

--0.00

-520.39%-0.68

-49.75%-0.24

---0.11

---0.16

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

